ArticleBlood cancer journal2025

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.

Rongtao Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.